Scarica l'app Stockscreener
4.37
4.59%
-0.21
Dopo l'orario di chiusura:
4.36
-0.010
-0.23%
Evoke Pharma Inc Azioni (EVOK) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
3.55%
1.7355
|
1.676 | 1.5629 | 1.1314 | 0.8104 |
Operating Expenses
|
9.18%
3.2367
|
3.5639 | 3.1663 | 2.9158 | 2.9655 |
| Interest Income/Expense |
1.09%
0.1247
|
0.126 | 0.126 | 0.1247 | 0.1233 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
9.18%
3.2367
|
3.5639 | 3.1663 | 2.9158 | 2.9655 |
| Operating Income/Loss |
20.48%
-1.5012
|
-1.8879 | -1.6034 | -1.7844 | -2.1551 |
| Nonoperating Income/Loss |
20.99%
-0.0786
|
-0.0995 | -0.0905 | -0.0835 | -0.088 |
| Income/Loss From Continuing Operations Before Tax |
3.55%
1.7355
|
1.676 | 1.5629 | -1.8679 | -2.2431 |
| Income/Loss From Continuing Operations After Tax |
20.51%
-1.5798
|
-1.9874 | -1.6939 | -1.8679 | -2.2431 |
|
Net Income/Loss
|
20.51%
-1.5798
|
-1.9874 | -1.6939 | -1.8679 | -2.2431 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.0821
|
- | 3.3431 | 3.3431 | 3.3431 |
| Diluted Average Shares |
9.0821
|
- | 3.3431 | 3.3431 | 3.3431 |
| Basic Earnings Per Share |
71.19%
-0.17
|
-0.59 | -0.51 | -0.56 | -0.67 |
| Diluted Earnings Per Share |
71.19%
-0.17
|
-0.59 | -0.51 | -0.56 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.79%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):